Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance.
- NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_assertion description "[Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-?B and C/EBP-? significantly reduced LCN2 promoter activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance.
- NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_assertion evidence source_evidence_literature NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance.
- NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_assertion SIO_000772 24570342 NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance.
- NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_assertion wasDerivedFrom befree-2016 NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance.
- NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_assertion wasGeneratedBy ECO_0000203 NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1158211.RAPyeI4dU8igWF5KER6UUxQ_SHVPSF2sBt5Cs3hW8FOS0130_provenance.